Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00318851 · ClinicalTrials.gov registry record · Phase 3
Carotid Artery Stenting With Protection Registry
A Phase 3 study, sponsored by Providence Health & Services.
- Completed
- Registry status
- Phase 3
- Development phase
- 62
- Enrollment target
NCT00318851 is a Phase 3 study that has completed, run by Providence Health & Services. The registered enrollment target is 62 participants.
The verdict
NCT00318851, a Phase 3 study, has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate ischemic events and neuropsychological changes after carotid artery angioplasty and stenting with a neuroprotection device.
Interventions
- DEVICE Carotid Stent with Distal Protection Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2003-09 |
| Est. Completion | 2007-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00318851
The ClinicalTrials.gov registry entry for NCT00318851 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carotid Stent with Distal Protection Device is the first listed.
NCT00318851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00318851 about?
NCT00318851 is a clinical study titled "Carotid Artery Stenting With Protection Registry". The purpose of this study is to evaluate ischemic events and neuropsychological changes after carotid artery angioplasty and stenting with a neuroprotection device.
What is the current status of trial NCT00318851?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 62 participants. The study started on 2003-09. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00318851?
The interventions under investigation include: Carotid Stent with Distal Protection Device (DEVICE).
Who is sponsoring clinical trial NCT00318851?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.